Researchers from the LMS and LMB have discovered how the D2-I protein complex identifies and repairs DNA damage, a breakthrough that promises to enhance cancer treatments by improving our understanding of DNA repair pathways. This collaboration could pave the way for more effective therapies by targeting the mechanisms that cancer cells use to resist treatment.
A collaboration between researchers at the UK’s two core-funded Medical Research Council Institutes—the Laboratory of Medical Sciences (LMS) in London and the Laboratory of Molecular Biology (LMB) in Cambridge—has unraveled a decades-old mystery, potentially leading to improved cancer treatments in the future.
The work, which uncovered the basic mechanism of how one of our most vital DNA repair systems recognizes DNA damages and initiates their repair, has eluded researchers for many years. Using cutting-edge imaging techniques to visualize how these DNA repair proteins move on a single molecule of DNA, and electron microscopy to capture how they “lock-on” to specific DNA structures, this research opens the way to more effective cancer treatments.
The collaboration between the laboratories of Professor David Rueda (LMS) and Dr Lori Passmore (LMB) has been a brilliant example of how #teamscience can bear fruitful results and underscores the importance of these two institutes in driving forward research that unlocks the fundamental mechanisms of biology which will underpin the future translation of that work into improvements in human health.
A single molecule of DNA (not directly visible) is captured using microscopic beads (the large circles). Each of the red, green, or yellow dots moving between the beads represents a FANCD2I-FANCI protein complex sliding along the DNA molecule, monitoring it for damage. Credit: MRC Laboratory of Medical Sciences
Unraveling the DNA Repair Mechanism
The researchers were working on a DNA repair pathway, known as the Fanconi Anaemia [FA] pathway, which was identified more than twenty years ago. DNA is constantly damaged throughout our lives by environmental factors including UV light from the sun, alcohol use, smoking, pollution, and exposure to chemicals. One way in which DNA becomes damaged is when it is “cross-linked”, which stops it being able to replicate and express genes normally. In order to replicate itself and to read and express genes, the two strands of the DNA double helix first has to unzip into single strands. When DNA is cross-linked, the “nucleotides” (the “steps” in the double-helix ladder of DNA) of the two strands become stuck together, preventing this unzipping.
The accumulation of DNA damages including cross-linking can lead to cancer. The FA pathway is active throughout our lives and identifies these damages and repairs them on an ongoing basis. Individuals who have mutations that make this pathway less effective are far more susceptible to cancers. Although the proteins involved in the FA pathway were discovered some time ago, a mystery remained over how they identified the cross-linked DNA and started the process of DNA repair.
The team from the MRC LMS sister institution, the LMB in Cambridge, led by Lori Passmore, had previously identified that the FANCD2-FANCI (D2-I) protein complex, which acts in one of the first steps of the FA pathway, clamps onto DNA, thereby initiating DNA repair at crosslinks. However, key questions remained: how does D2-I recognize crosslinked DNA, and why is the D2-I complex also implicated in other types of DNA damage?
The research, published in the journal Nature, used a combination of cutting-edge scientific techniques to show that the D2-I complex slides along the double-stranded DNA, monitoring its integrity, and has also elegantly visualized how it recognizes where to stop, allowing the proteins to move and lock together at that point to initiate DNA repair.
Advanced Techniques Shed Light on Molecular Interactions
Artur Kaczmarczyk and Korak Ray in David Rueda’s Single Molecule Imaging group, working with Pablo Alcón in Lori Passmore’s group, used a state-of-the-art microscopy technique known as “correlated optical tweezers and fluorescence imaging” to explore how the D2-I complex slides along a double-stranded DNA molecule.
Using optical tweezers, they could catch a single DNA molecule between two beads, which allowed them to precisely manipulate the DNA and incubate it with chosen proteins. Using fluorescently labeled D2-I and single-molecule imaging, they observed how individual D2-I complexes bind to and slide along DNA, scanning the double helix. They discovered that rather than recognizing the crosslink between the two strands of DNA directly, the FA clamp instead stops sliding when it reaches a single-stranded DNA gap, a region where one of the two strands of DNA is missing.
The video shows the FANCD2-FANCI complex clamping to DNA in order to repair it. Credit: MRC Laboratory of Medical Sciences, MRC Laboratory for Molecular Biology
Using cryo-electron microscopy, a powerful technique which can visualize proteins at a molecular level, the researchers next determined the structures of the D2-I complex both in its sliding position and stalled at the junction between single-stranded and double-stranded DNA. This revealed that the contacts D2-I makes with this single-stranded–double-stranded DNA junction are distinct from the contacts it makes with double-stranded DNA alone. This allowed them to identify a specific portion of the FANCD2 protein, called the “KR helix” that they showed in their single-molecule imaging experiments is critical for recognizing and stalling at the single-stranded DNA gaps.
Working with Guillaume Guilbaud and Julian Sale in the LMB’s PNAC Division, and Themos Liolios and Puck Knipscheer at the Hubrecht Institute, Netherlands, they further showed that the D2-I complex’s ability to stall at these junctions using the KR helix is critical for DNA repair by the FA pathway.
When DNA normally replicates in our cells, it unzips the two DNA strands and copies each single strand. This creates a ‘replication fork’ where the original DNA strands are unwound and new double-stranded DNA is formed on each strand. However, when this fork reaches a DNA crosslink, the strands cannot be unzipped, stalling the usual DNA replication process. This stalled replication fork thus contains exposed single-stranded gaps where the DNA has been unwound but not replicated. This research has shown that it is these junctions between single- and double-stranded DNA at the stalled replication fork that the D2-I protein complex latches tightly onto.
Implications for Cancer Treatment and Beyond
Not only does this allow D2-I complex to bring other FA pathway proteins to the DNA crosslink to initiate repair, but it also anchors the remaining double-stranded DNA, protecting the stalled “replication fork” from enzymes in the cell that would chew up the exposed end of the DNA strand and further damage the DNA. This work has shown that it is DNA structures within the replication fork that stalls as a result of cross-linked DNA, rather than the cross-linked DNA itself, that triggers the D2-I complex to stop sliding and clamp on to DNA to initiate repair. These stalled replication forks appear in many types of DNA damage, explaining the broad role of the D2-I complex in other forms of DNA repair as well as via the FA pathway.
Understanding the process of DNA repair, and, importantly, why it fails, holds huge importance as DNA damage is a key factor in many diseases. Critically, many cancer drugs, for example, Cisplatin, work by inducing such serious cellular damage to cancer cells that they stop dividing and die. In such cases, DNA repair pathways—such a vital physiological process in normal life—can be hijacked by cancer cells that use them to resist the effects of chemotherapy drugs. Understanding the mechanistic basis of the first step in the DNA repair pathway may lead to ways of sensitizing patients so that cancer drugs can be more effective in the future.
Reference: “FANCD2–FANCI surveys DNA and recognizes double- to single-stranded junctions” by Pablo Alcón, Artur P. Kaczmarczyk, Korak Kumar Ray, Themistoklis Liolios, Guillaume Guilbaud, Tamara Sijacki, Yichao Shen, Stephen H. McLaughlin, Julian E. Sale, Puck Knipscheer, David S. Rueda and Lori A. Passmore, 31 July 2024, Nature.
DOI: 10.1038/s41586-024-07770-w
This work was funded by UKRI MRC, the Wellcome Trust, the European Research Council, and the EMBO.
News
Urban Microbes Are Eating Disinfectants – Are We Fueling a New Health Threat?
New research reveals that microbes in urban environments are evolving to withstand the very cleaning agents designed to eliminate them. The study also uncovers new strains in Hong Kong, previously only found in the [...]
Startling Study Shows High-Potency Cannabis Alters DNA
The study shows that frequent use of high-potency cannabis alters DNA, affecting genes related to energy and immune function. These changes differ between those with and without psychosis, suggesting cannabis use could influence mental health through biological [...]
New nanotherapy targets artery inflammation in cardiovascular disease
Inflammation of the arteries is a primary precursor and driver of cardiovascular disease—the No. 1 killer of people in the United States. This inflammation is associated with the buildup of dangerous plaque inside the [...]
Revolutionary Nanoparticle Therapy for Prostate Cancer
A groundbreaking research effort involving teams from the University of Virginia, Mount Sinai, the University of Michigan, the University of Texas, and others has displayed the clinical efficacy of an innovative therapy that utilizes nanoparticles and [...]
Antibody engineering drives innovation in drug development
Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound [...]
Breakthrough Study Reveals How Bladder Cancer Starts and Spreads
Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal circular DNA in tumor cells drives resistance to therapy. These discoveries open new therapeutic avenues. A groundbreaking study led by [...]
AI and Quantum Mechanics Accelerate Drug Discovery
A recent article published in the Journal of Chemical Information and Modeling researchers at Southern Methodist University (SMU) have developed SmartCADD, an open-source virtual tool designed to speed [...]
Targeting ‘undruggable’ diseases: Researchers reveal new levels of detail in targeted protein degradation
Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called protein degraders which can be deployed to combat what have previously been regarded as "undruggable" diseases, [...]
Revolutionizing Virology: AI Discovers Over 160,000 New RNA Viruses
Largest discovery of new virus species sheds light on the hidden virosphere. Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under our feet and in every [...]
Cardiac Crisis: COVID-19 Doubles Risk of Heart Attacks, Strokes, and Death
Research indicates that COVID-19 survivors face doubled risks of severe cardiac events for years after recovery, especially if hospitalized. People with A, B, or AB blood types are particularly vulnerable, highlighting the need for personalized approaches [...]
AI steps into science limelight with Nobel wins
For long periods of its history, artificial intelligence has lurked in the hinterland of science, often unloved and unfunded—but two Nobel prizes in one week suggest its time in the sunshine has finally arrived. [...]
MIT Scientists Shed New Light on the Critical Brain Connections That Define Consciousness
A new study provides further evidence that consciousness depends on communication between the brain’s sensory and cognitive regions in the cortex. Our brains are constantly making predictions about our surroundings, enabling us to focus [...]
Common Chemicals Found in Shampoo and Plastic Could Be Quietly Disrupting Your Heart’s Rhythm
UC study of Fernald data links environmental phenols to heart toxicities Environmental phenols are present in numerous everyday consumer products, serving as preservatives in packaged foods, parabens in shampoos, and bisphenol A (BPA) in [...]
Revolutionary Brain Tech Offers New Hope for Stroke and Injury Recovery
University of Pittsburgh researchers report that deep brain stimulation (DBS) can effectively enhance motor functions in individuals with arm and hand paralysis due to brain injuries, with promising results from early human and monkey [...]
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]